Inverness Counsel’s Evolus EOLS Stock Holding History

Inverness Counsel’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-16,000	Closed	-$361K	–	121
2019 Q1	$361K	Hold	16,000	–	–	0.02%	89
2018 Q4	$190K	Buy	+16,000	New	+$228K	0.01%	111

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wafra Inc New York $5.95M AUM 6.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Inverness Counsel's EOLS Position: Q2 2019 in Review

Inverness Counsel sold out of Evolus (EOLS) in Q2 2019, closing a stake of 16,000 shares — an estimated $361K sold.

Inverness Counsel first reported a position in EOLS in Q4 2018 and held it in 2 quarters. The position peaked at $361K in Q1 2019. 106 funds tracked by Wall St. Rank hold EOLS as of Q2 2019.

Inverness Counsel reported no remaining Evolus position as of Q2 2019 after selling out during the quarter.
Inverness Counsel sold 16,000 Evolus shares in Q2 2019, an estimated $361K.
Inverness Counsel first reported a position in Evolus in Q4 2018 and held it in 2 quarters.
Inverness Counsel's Evolus position peaked at $361K in Q1 2019.
106 funds tracked by Wall St. Rank held Evolus as of Q2 2019.

Based on Inverness Counsel's 13F filing for Q2 2019, filed 7 Aug 2019.